PSIAC
Sad Pill Bild Bildrechte: © spinetta / Fotolia

Oops!

Sie verwenden eine veraltete Version Ihres Internetbrowsers und können nicht auf die Inhalte der Seite zugreifen.
Bitte aktualisieren Sie Ihre Browserversion.

PSIAC

Literaturverzeichnis

Erweiterte Suche
Corti N. Eur J Clin Pharmacol. Oct 2009; 65(10): 999-1006 Pubmed [9397]
Cortopassi J. Am J Health Syst Pharm. Oct 2020; 77(22): 1846-1851 Pubmed [9833]
Corvol JC. Arch Neurol. Dec 2007; 64(12): 1721-6 Pubmed [10947]
Coscun, Zoroglu (2008) J Clin Psychopharmacol 28:723-725 [2808]
Coskun Y. J Clin Gastroenterol. Jul 2012; 46(6): 529-30 Pubmed [10918]
Cosmai L. J Nephrol. Dec 2015; 28(6): 647-57 Pubmed [7887]
Cossart AR. Transl Androl Urol. May 2019; 8(Suppl 2): S198-S213 Pubmed, Volltext, DOI [7853]
Costa ACC. J Clin Pharmacol. Aug 2020; 60(8): 1076-1086 Pubmed [9615]
Costa FH. Arq Neuropsiquiatr. Aug 2012; 70(8): 617-20 Pubmed [8318]
Costa S. Curr Opin Crit Care. Dec 2001; 7(6): 379-83 Pubmed [7234]
Costello LE. J Clin Psychopharmacol. Apr 1995; 15(2): 139-41 Pubmed [1213]
Cotreau MM. Clin Pharmacol Drug Dev. Mar 2015; 4(2): 137-42 Pubmed [7735]
Cottrell ML. Clin Pharmacokinet. Nov 2013; 52(11): 981-94 Pubmed, Volltext, Springer [6637]
Coulter DM. Am J Psychiatry. Jan 1995; 152(1): 122-5 Pubmed [1355]
Counsell H. BMJ Case Rep. Jan 2013; 2013 Pubmed, Volltext [9638]
Coupland C. BMJ. Aug 2011; 343: d4551 Pubmed, Volltext, DOI [3377]
Court MH. Antimicrob Agents Chemother. Jul 2014; 58(7): 4145-52 Pubmed, Volltext, DOI [5029]
Court MH. Drug Metab Dispos. Sep 2003; 31(9): 1125-33 Pubmed [4380]
Cousins MJ. Lancet. Apr 1972; 1(7753): 751-2 Pubmed [5625]
Couzin-Frankel J. Science. Nov 2021; 374(6569): 799-800 Pubmed [11349]
COVID-19: reminder of risk of serious side effects with chloroquine and hydroxychloroquine. EMA. Stand May 2020. https://www.ema.europa.eu/en/documents/press-release/covid-19-reminder-risk-serious-side-effects-chloroquine-hydroxychloroquine_en.pdf [10090]
Coyle CM. Handb Clin Neurol. Jan 2013; 114: 271-81 Pubmed [9117]
Cozanitis DA. Experientia. Dec 1981; 37(12): 1326-7 Pubmed [9997]
Cozza KL, Amstrong SC, Oesterheld JR , Concise guide to drug interaction. Principles for medical practice. Cytochrome P450s, UGTS, P-glycoproteins, American Psychiatric Publishing, Washington DC (2003) [2710]
Cozza KL, Amstrong SC, Oesterheld JR , Concise guide to drug interaction. Principles for medical practice.Cytochrome P450s, UGTS, P-glycoproteins, American Psychiatric Publishing, Washington DC (2003) [2789]
Cozza KL, Amstrong SC, Oesterheld JR (2003.) Concise guide to drug interaction principles for medical practice. Cytochrome P450s, [2606]
Cozza KL, Amstrong SC, Oesterheld JR (2003) Concise guide to drug interaction principles for medical practice. Cytochrome P450s, UGTS, P glycoproteins [2589]
Cozza KL, Amstrong SC, Oesterheld JR (2003) Concise guide to drug interaction principles for medical practice. Cytochrome P450s, UGTS, P glycoproteins: p 327 [2613]
Cozza KL, Amstrong SC, Oesterheld JR (2003) Concise guide to drug interaction principles for medical practice. Cytochrome P450s,UGTS, P glycoproteins [2586]
Cozza KL, Amstrong SC, Oesterheld JR (2003), Concise guide to drug interaction, principles for medical practice. Cytochrome P450s, UGTS, P-glycoproteins: p 201 [2340]
Cozza KL, Amstrong SC, Oesterheld JR (2003). Concise guide to drug interaction principles for medical practice. Cytochrome P450s, UGTS, P glycoproteins [2600]
Cozza KL, Amstrong SC, Oesterheld JR, Concise guide to drug interaction. Principles for medical practice. Cytochrome P450s, UGTS, P-glycoproteins, American Psychiatric Publishing, Washington DC (2003) [2733]
Cozza KL, Armstrong SC, Oesterheld JR (2003), Concise guide to drug interaction principles for medical practice. Cytochrome P450s, UGTS, P-glycoproteins: 51, 236 [2559]
Cozza KL. Psychosomatics. Sep 2012; 53(5): 499-502 Pubmed [4193]
Cozzolino et al. Clin Europea (1972) 11, 593 [2382]
Crabtree BL. Am J Psychiatry. Aug 1991; 148(8): 1060-3 Pubmed [1701]
Craig JM. Endocrinology. May 2021; 162(5) Pubmed [10669]
Cranshaw T. Schizophr Bull. Jul 2020; 46(4): 751 Pubmed, Volltext, DOI [9955]
Crass RL. Pharmacotherapy. Feb 2019; 39(2): 182-195 Pubmed [8226]
Crauwels H, 2010. Pharmacokinetic interaction study between TMC278, a next-generation NNRTI, and methadone. Abstract WEPE0089, presented at the XVIII International AIDS Conference, July 18–23, 2010, Vienna, Austria [3412]
Crauwels H. AIDS Rev. Apr 2013; 15(2): 87-101 Pubmed [6553]
Crauwels HM. Int J Clin Pharmacol Ther. Feb 2014; 52(2): 118-28 Pubmed [6556]
Crauwels HM. J Clin Pharmacol. Feb 2014; 54(2): 133-40 Pubmed [6568]
Cravens MG. Cureus. Jan 2019; 11(1): e3827 Pubmed, Volltext, DOI [7162]
Crawford P. CNS Drugs. Jan 2002; 16(4): 263-72 Pubmed [9276]
Crettol S. Clin Pharmacol Ther. Dec 2005; 78(6): 593-604 Pubmed [1832]
Crettol S. Clin Pharmacol Ther. Dec 2006; 80(6): 668-81 Pubmed [146]
Crettol S. Curr Pharm Des. Jan 2010; 16(2): 204-19 Pubmed [5021]
Crewe HK. Biochem Pharmacol. Jan 1997; 53(2): 171-8 Pubmed [4019]
Crewe HK. Br J Clin Pharmacol. Sep 1992; 34(3): 262-5 Pubmed, Volltext [5004]
Crippin JS. Am J Gastroenterol. Apr 1993; 88(4): 590-2 Pubmed [6807]
Croissant B. Am J Drug Alcohol Abuse. Jan 2008; 34(5): 534-40 Pubmed [10641]
Crommentuyn KM. Clin Infect Dis. Apr 2004; 38(8): e73-5 Pubmed [6428]
Cronson AJ. Am J Psychiatry. Jul 1978; 135(7): 856-7 Pubmed [1681]
Cropp JS. Pharmacotherapy. Sep 1997; 17(5): 917-28 Pubmed [4758]
Cropp, J.S. Pharmacotherapy. Volume 17(Issue 5): Pages 917-928 Pubmed [9158]
Cross HM. S Afr Med J. Mar 2018; 108(4): 271-274 Pubmed [7173]
Crowe A. Toxicol Appl Pharmacol. May 2012; 260(3): 294-302 Pubmed [159]
Crowe S. Anesthesiology. Feb 2003; 98(2): 574-5 Pubmed [9849]
Crowley JJ. Clin Pharmacol Ther. Sep 1987; 42(3): 334-40 Pubmed [2734]
Crucitti A. Curr Med Res Opin. Nov 2010; 26(11): 2579-88 Pubmed [12934]
Cruddas L. J Eur Acad Dermatol Venereol. Jun 2017; 31(6): 952-963 Pubmed [6951]
Crussell-Porter LL. Arch Intern Med. Jan 1993; 153(1): 102-4 Pubmed [5892]
Cruz Rodriguez JB. Ann Transl Med. Mar 2021; 9(6): 519 Pubmed [11045]
Csajka C. Clin Pharmacokinet. Dec 2016; 55(12): 1521-1533 Pubmed [7562]
Csik V, Molnar J. Possible adverse interaction between clozapine and ampicillin in an adolescent with schizophrenia. J Child Adolesc Psychopharmacol (1994) 4, 123-8 [1108]
Csuka M. JAMA. May 1986; 255(17): 2315-9 Pubmed [8882]
Cuadrado A et al. Method Find exp Clin Pharmacol (1996) 18 (Suppl C), 65 [717]
Cuadrado A. Eur J Pharmacol. Mar 2003; 465(1-2): 43-52 Pubmed [9500]
Cuadrado A. Pharmacol Res. May 2005; 51(5): 489-96 Pubmed [9321]
Cubeddu Curr Cardiol Rev. 2009 Aug;5(3):166-76.-122 [3083]
Cubeddu LX. Am J Ther. Nov 2003; 10(6): 452-7 Pubmed [7795]
Cubeddu LX. Curr Cardiol Rev. Aug 2009; 5(3): 166-76 Pubmed [12718]
Cudmore J. Can Fam Physician. Jan 2014; 60(1): 53-6 Pubmed, Volltext [5310]
Cuesta Grueso C. Farm Hosp. May 2006; 30(3): 149-53 Pubmed [7267]
Cueva JE. J Am Acad Child Adolesc Psychiatry. Apr 1996; 35(4): 480-90 Pubmed [11701]
Cui C. Curr Drug Metab. Jan 2020; 21(6): 427-435 Pubmed [10786]
Culm-Merdek KE. Br J Clin Pharmacol. Nov 2005; 60(5): 486-93 Pubmed, Volltext, DOI [7699]
Culm-Merdek KE. Clin Pharmacol Ther. Mar 2006; 79(3): 243-54 Pubmed [11683]
Culmsee C. Stroke. May 2004; 35(5): 1197-202 Pubmed [3194]
Cundy KC. Clin Pharmacokinet. Feb 1999; 36(2): 127-43 Pubmed [7095]
Cuñetti L. Transplant Proc. Mar 2018; 50(2): 461-464 Pubmed [13604]
Cunningham D. Am J Emerg Med. Sep 2021 Pubmed [11127]
Cunningham RF. Clin Pharmacokinet. Mar 1981; 6(2): 135-51 Pubmed [7553]
Curis E. Infection. Aug 2015; 43(4): 473-81 Pubmed [5650]
Curran A. Expert Rev Anti Infect Ther. Dec 2011; 9(12): 1115-8 Pubmed [8748]
Curran MP. Drugs. Jan 2010; 70(2): 191-213 Pubmed [4142]
Curry ML, Curry SH, Marroum PJ. Interaction of phenothiazine and related drugs and caffeinated beverages. DICP Ann Pharmacother (1991) 25, 437-8 [857]
Curry MP. N Engl J Med. Dec 2015; 373(27): 2618-28 Pubmed [7903]
Curry SH. Br J Pharmacol. Jul 1971; 42(3): 403-11 Pubmed, Volltext [900]
Curry SH. Eur J Clin Pharmacol. Jan 1985; 29(4): 429-33 Pubmed [528]
Curry SH. Eur J Clin Pharmacol. Jan 1987; 32(3): 317-20 Pubmed [565]
Curtis BR. Immunohematology. Jan 2014; 30(2): 95-101 Pubmed [8144]
Curtis LH. Am J Med. Feb 2003; 114(2): 135-41 Pubmed [4943]
Cusato J. J Antimicrob Chemother. Jun 2018; 73(6): 1659-1664 Pubmed [7206]
Custodio J, West S, Vu A, et al., Lack of clinically relevant effect of bictegravir on metformin pharmacokinetics and pharmacodynamics. Paper presented at: 18th International Workshop on Clinical Pharmacology of Antiviral Therapy; 2017; Chicago, IL. Available from: http://www.natap.org/2017/Pharm/Pharm_32.htm. Accessed May 29, 2018. [7479]
Custodio J, West S, Vu A, et al., Lack of clinically relevant effect of bictegravir on metformin pharmacokinetics and pharmacodynamics. Paper presented at: 18th International Workshop on Clinical Pharmacology of Antiviral Therapy; 2017; Chicago, IL. Available from: http://www.natap.org/2017/Pharm/Pharm_32.htm. Accessed May 29. [7478]
Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018. [7488]
Custodio J, West S, Vu A, et al., Pharmacokinetics of bictegravir administered twice daily with rifampin. Paper presented at: The Conference on Retroviruses and Opportunistic Infections (CROI); 2018; Boston, MA. Available from: http://www.croiconference.org/sessions/ pharmacokinetics-bictegravir-administered-twice-daily-combinationrifampin. Accessed May 29, 2018. [7489]